Synvisc or synvisc-one
Products billed under this code include Synvisc, SynviscOne.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Synvisc, SynviscOne.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Synvisc | Genzyme Corporation | 58468-0090-01 | 48 | $288.528 |
| SynviscOne | Genzyme Corporation | 58468-0090-03 | 48 | $288.528 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $6.011 | −$0.007 | 1 MG | Synvisc or synvisc-one | v1, posted September 17, 2026 |
| 3Q26 | $6.018 | −$0.945 | 1 MG | Synvisc or synvisc-one | v1, posted September 15, 2026 |
| 2Q26 | $6.963 | −$0.598 | 1 MG | Synvisc or synvisc-one | v1, posted September 15, 2026 |
| 1Q26 | $7.561 | −$0.39 | 1 MG | Synvisc or synvisc-one | v1, posted September 15, 2026 |
| 4Q25 | $7.951 | −$1.139 | 1 MG | Synvisc or synvisc-one | v1, posted September 8, 2026 |
| 3Q25 | $9.09 | −$0.162 | 1 MG | Synvisc or synvisc-one | v1, posted March 10, 2026 |
| 2Q25 | $9.252 | +$0.089 | 1 MG | Synvisc or synvisc-one | v1, posted March 10, 2026 |
| 1Q25 | $9.163 | +$0.008 | 1 MG | Synvisc or synvisc-one | v1, posted December 19, 2025 |
| 4Q24 | $9.155 | +$0.338 | 1 MG | Synvisc or synvisc-one | v1, posted June 11, 2025 |
| 3Q24 | $8.817 | −$0.059 | 1 MG | Synvisc or synvisc-one | v1, posted June 11, 2025 |
| 2Q24 | $8.876 | −$0.246 | 1 MG | Synvisc or synvisc-one | v1, posted March 11, 2025 |
| 1Q24 | $9.122 | +$0.352 | 1 MG | Synvisc or synvisc-one | v1, posted December 19, 2024 |
| 4Q23 | $8.77 | −$0.847 | 1 MG | Synvisc or synvisc-one | v1, posted October 10, 2024 |
| 3Q23 | $9.617 | −$0.031 | 1 MG | Synvisc or synvisc-one | v1, posted June 5, 2024 |
| 2Q23 | $9.648 | −$0.139 | 1 MG | Synvisc or synvisc-one | v1, posted February 23, 2024 |
| 1Q23 | $9.787 | −$0.349 | 1 MG | Synvisc or synvisc-one | v1, posted December 6, 2023 |
| 4Q22 | $10.136 | +$0.365 | 1 MG | Synvisc or synvisc-one | v1, posted June 22, 2023 |
| 3Q22 | $9.771 | −$0.665 | 1 MG | Synvisc or synvisc-one | v1, posted June 9, 2023 |
| 2Q22 | $10.436 | +$0.002 | 1 MG | Synvisc or synvisc-one | v1, posted December 14, 2022 |
| 1Q22 | $10.434 | −$0.802 | 1 MG | Synvisc or synvisc-one | v1, posted June 8, 2022 |
| 4Q21 | $11.236 | +$0.351 | 1 MG | Synvisc or synvisc-one | v1, posted June 2, 2022 |
| 3Q21 | $10.885 | +$0.721 | 1 MG | Synvisc or synvisc-one | v1, posted June 2, 2022 |
| 2Q21 | $10.164 | −$0.507 | 1 MG | Synvisc or synvisc-one | v1, posted March 1, 2022 |
| 1Q21 | $10.671 | – | 1 MG | Synvisc or synvisc-one | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.